12.02.24 |
Unilever Market-Perform |
Bernstein Research |
|
12.02.24 |
Diageo Sell |
Deutsche Bank AG |
|
12.02.24 |
BAT Neutral |
JP Morgan Chase & Co. |
|
12.02.24 |
BP Outperform |
RBC Capital Markets |
|
12.02.24 |
BAT Neutral |
Goldman Sachs Group Inc. |
|
12.02.24 |
AstraZeneca Overweight |
Barclays Capital |
|
09.02.24 |
GSK Buy |
UBS AG |
|
09.02.24 |
AstraZeneca Sell |
UBS AG |
|
09.02.24 |
Unilever Sell |
UBS AG |
|
09.02.24 |
Unilever Underweight |
JP Morgan Chase & Co. |
|
09.02.24 |
Unilever Buy |
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
|
09.02.24 |
Unilever Overweight |
Barclays Capital |
|
09.02.24 |
Unilever Underperform |
Jefferies & Company Inc. |
|
09.02.24 |
GSK Buy |
Jefferies & Company Inc. |
|
09.02.24 |
AstraZeneca Sell |
Deutsche Bank AG |
|
08.02.24 |
Diageo Underperform |
RBC Capital Markets |
|
08.02.24 |
GSK Buy |
Deutsche Bank AG |
|
08.02.24 |
AstraZeneca Sell |
UBS AG |
|
08.02.24 |
BAT Neutral |
UBS AG |
|
08.02.24 |
Unilever Market-Perform |
Bernstein Research |
|
08.02.24 |
BAT Buy |
Jefferies & Company Inc. |
|
08.02.24 |
AstraZeneca Overweight |
JP Morgan Chase & Co. |
|
08.02.24 |
BAT Neutral |
JP Morgan Chase & Co. |
|
08.02.24 |
Unilever Underweight |
JP Morgan Chase & Co. |
|
08.02.24 |
AstraZeneca Hold |
Jefferies & Company Inc. |
|
08.02.24 |
Unilever Sector Perform |
RBC Capital Markets |
|
07.02.24 |
BAT Buy |
Jefferies & Company Inc. |
|
07.02.24 |
BP Buy |
UBS AG |
|
07.02.24 |
BP Underweight |
JP Morgan Chase & Co. |
|
07.02.24 |
Vodafone Group Neutral |
JP Morgan Chase & Co. |
|
06.02.24 |
BP Overweight |
Barclays Capital |
|
06.02.24 |
BP Underweight |
JP Morgan Chase & Co. |
|
06.02.24 |
BP Outperform |
RBC Capital Markets |
|
06.02.24 |
BP Hold |
Jefferies & Company Inc. |
|
06.02.24 |
GSK Buy |
UBS AG |
|
06.02.24 |
Vodafone Group Buy |
UBS AG |
|
06.02.24 |
BP Buy |
UBS AG |
|
05.02.24 |
BAT Buy |
Jefferies & Company Inc. |
|
05.02.24 |
Shell Buy |
Jefferies & Company Inc. |
|
05.02.24 |
BP Outperform |
RBC Capital Markets |
|